Sphera Funds Management Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Sphera Funds Management Ltd
CRD #312614
SEC #802-120694
CIK #0001496201
AUM
Employees
Phone97236845535
Address4 Yitzhak Sade St
Tel Aviv, Israel
Source [IAPD] [EDGAR] [Website]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Sector Form 13F Holdings Value ($M)
Mineralys Therapeutics Inc 36.3
Teva Pharmaceutical Industries Ltd 34.2
Tower Semiconductor Ltd 25.6
Nova Measuring Instruments Ltd 23.2
Cytokinetics Inc 19.7
Bridgebio Pharma Inc 18.2
Biogen IDEC Inc 17.0
Ultragenyx Pharmaceutical Inc 17.0
Syndax Pharmaceuticals Inc 16.9
UNUM Therapeutics Inc 16.0
View All
Holdings by Sector ($M)
1500120090060030002013201720222027
Type Form D Funds Date Sold AUM
HF Sphera Master Fund LP [2021-03-03] 30.3 M 849.7 M
Filed 2025-04-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Itschak Shrem Director 8 3
Doron Breen Director 5 3
Israel Mor Director 4 3
Eddy Shalev Director 6 2
Ron Senator Director 2 2
Mali Sagie Director 2 2
Erez Mor Director 1 1
Ehud Gelbard Director 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001496201]
3 [0001496201]
4 [0001496201]
SC 13G [0001496201]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sphera Funds Management Ltd Outlook Therapeutics Inc [2025-03-03]
Sphera Funds Management Ltd Chemomab Therapeutics Ltd [2024-08-20]
Sphera Funds Management Ltd Skye Bioscience Inc [2024-02-08]
Sphera Funds Management Ltd Jasper Therapeutics Inc [2023-10-10]
Sphera Funds Management Ltd Promis Neurosciences Inc [2023-08-30]
Sphera Funds Management Ltd Praxis Precision Medicines Inc [2023-06-22]
Sphera Funds Management Ltd Inozyme Pharma Inc [2023-03-07]
Sphera Funds Management Ltd Altimmune Inc [2021-08-31]
Sphera Funds Management Ltd Cyclacel Pharmaceuticals Inc [2021-03-18]
Sphera Funds Management Ltd Evoke Pharma Inc [2020-02-11]
View All
Firm Profile (Form ADV)
Fund TypesHedge Fund
LEI254900DT9451Z70GV733
Form 3/4/5 Subject 2011 - 2026
Werewolf Therapeutics Inc
Sphera Global Healthcare GP Ltd
Sphera Global Healthcare Management LP
Sphera Funds Management Ltd
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Werewolf Therapeutics Inc HOWL
Common Stock
2021-05-04 Conversion 312,997
Werewolf Therapeutics Inc HOWL
Common Stock
2021-05-04 Buy 475,000 $16.00 7,600,000
Werewolf Therapeutics Inc HOWL
Series B Preferred Stock · derivative
2021-05-04 Conversion 2,713,410 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com